Economic portfolio
ICICI Prudential Pharma Healthcare and Diagnostics Fund
ICICI ICICI Prudential Mutual Fund Jul 2026 — Jul 2026 1 months
Data periodFund holdingsJul 2026NSE prices23 Oct 2026Data status →
Continues as ICICI Prudential Healthcare Fund from Aug 2026 (93% the same holdings).
A renamed or re-coded scheme starts a new history in the disclosures; the two parts are linked here, not merged.
Days to sell half: 31.6 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Jul 2026). Large positions in thinly traded stocks: an orderly exit would take weeks or months. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ICICI Prudential Healthcare FundICICI Prudential · 32 shared87.4%
- NIPPON INDIA PHARMA FUNDNippon India · 19 shared56.3%
- DSP Nifty Healthcare ETFDSP · 11 shared47.6%
- DSP Nifty Healthcare Index FundDSP · 11 shared47.6%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 11 shared47.6%
- Axis NIFTY Healthcare ETFAxis · 11 shared47.6%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 11 shared47.6%
- Nippon India Nifty Pharma ETFNippon India · 10 shared47.1%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
Holdings by value
Jul 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 13.16% | 863 Cr | 0.43 Cr | by Jul 2026 (1 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 8.77% | 575 Cr | 0.50 Cr | by Jul 2026 (1 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.80% | 446 Cr | 0.30 Cr | by Jul 2026 (1 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 6.25% | 410 Cr | 0.05 Cr | by Jul 2026 (1 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 5.67% | 372 Cr | 0.15 Cr | by Jul 2026 (1 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 5.30% | 348 Cr | 0.06 Cr | by Jul 2026 (1 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 5.16% | 338 Cr | 0.79 Cr | by Jul 2026 (1 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 4.06% | 266 Cr | 0.63 Cr | by Jul 2026 (1 mo+) |
| Medplus Health Services Limited | Consumer Services | Small Cap | 3.94% | 258 Cr | 0.37 Cr | by Jul 2026 (1 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 3.38% | 222 Cr | 0.57 Cr | by Jul 2026 (1 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 2.92% | 191 Cr | 0.17 Cr | by Jul 2026 (1 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 2.73% | 179 Cr | 64,361 | by Jul 2026 (1 mo+) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 2.52% | 166 Cr | 0.21 Cr | by Jul 2026 (1 mo+) |
| Blue Jet Healthcare Limited | Healthcare | Small Cap | 2.48% | 163 Cr | 0.26 Cr | by Jul 2026 (1 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 2.31% | 151 Cr | 0.06 Cr | by Jul 2026 (1 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 2.04% | 134 Cr | 0.03 Cr | by Jul 2026 (1 mo+) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 2.02% | 132 Cr | 0.23 Cr | by Jul 2026 (1 mo+) |
| Akums Drugs and Pharmaceuticals Limited | Healthcare | Small Cap | 1.96% | 129 Cr | 0.20 Cr | by Jul 2026 (1 mo+) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 1.92% | 126 Cr | 0.02 Cr | by Jul 2026 (1 mo+) |
| Entero Healthcare Solutions Limited | Consumer Services | Small Cap | 1.78% | 117 Cr | 0.09 Cr | by Jul 2026 (1 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 1.57% | 103 Cr | 0.07 Cr | by Jul 2026 (1 mo+) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 1.55% | 101 Cr | 0.17 Cr | by Jul 2026 (1 mo+) |
| Alivus Life Sciences Limited | Not classified | Small Cap | 1.38% | 90.39 Cr | 0.08 Cr | by Jul 2026 (1 mo+) |
| Medi Assist Healthcare Services Limited | Not classified | Small Cap | 1.31% | 86.20 Cr | 0.24 Cr | by Jul 2026 (1 mo+) |
| Hikal Limited | Not classified | Small Cap | 1.23% | 80.58 Cr | 0.36 Cr | by Jul 2026 (1 mo+) |
| Fine Organic Industries Limited | Not classified | Small Cap | 1.22% | 80.03 Cr | 0.02 Cr | by Jul 2026 (1 mo+) |
| Aarti Drugs Limited | Not classified | Small Cap | 1.20% | 78.86 Cr | 0.19 Cr | by Jul 2026 (1 mo+) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 1.16% | 75.87 Cr | 0.02 Cr | by Jul 2026 (1 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 0.84% | 55.40 Cr | 0.04 Cr | by Jul 2026 (1 mo+) |
| Windlas Biotech Limited | Not classified | Small Cap | 0.78% | 51.30 Cr | 0.06 Cr | by Jul 2026 (1 mo+) |
| Laxmi Dental Limited | Not classified | Small Cap | 0.78% | 50.96 Cr | 0.24 Cr | by Jul 2026 (1 mo+) |
| FDC Limited | Not classified | Small Cap | 0.77% | 50.20 Cr | 0.12 Cr | by Jul 2026 (1 mo+) |
| Indoco Remedies Limited | Not classified | Small Cap | 0.56% | 36.48 Cr | 0.17 Cr | by Jul 2026 (1 mo+) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 0.48% | 31.67 Cr | 0.10 Cr | by Jul 2026 (1 mo+) |
Half of its current holdings have been held for 1 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| No comparable position changes are available for this portfolio. | |||
Changes compare consecutive month-end disclosures for this portfolio only.